PFAS in Medtech
Per- and polyfluoroalkyl substances, known as PFAS, are a broad class of over 12,000 substances that are found in a variety of consumer, commercial and industrial products, including medical devices…
Per- and polyfluoroalkyl substances, known as PFAS, are a broad class of over 12,000 substances that are found in a variety of consumer, commercial and industrial products, including medical devices…
Artificial intelligence has been in the spotlight recently, but it is not a new concept to the Food and Drug Administration (FDA) or the medtech industry. AI advancements in the…
Outlining the facts and dispelling myths will inform policymaking to avoid overlap with current regulations and preserve the broad capacity of innovation to help patients.
Each year in the U.S., ethylene oxide sterilizes 20 billion medical devices, which are critical to preventing serious, even life-threatening, infections.
The VALID Act is carefully tailored to ensure continued access to tests offered by academic medical centers and other laboratories.
This report outlines a key data-driven summary of the U.S. COVID testing supply.
Modernizing regulation of diagnostic tests is essential to improve patient care and support innovation.
The ability to treat and address chronic non-healing wounds via the array of technologies that are available is imperative.
This brochure provides an overview of the Physician Payments Sunshine Act.
Proper servicing of complex, life-saving medical devices is vital to their safe and effective functioning and the safety of patients and device users.